Admedus is a medical technologies company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


YOUR CHOICE


Clinically superior solutions that last a lifetime

LATEST NEWS


Admedus to change financial year-end
Admedus Limited (ASX:AHZ) announced that the Company has changed its financial year-end from 30 June to 31 December. This change
Read more.
Admedus 2017 AGM webinar
The investor webinar from our AGM on 16 November 2017 is now available to view via this link – AHZ – AGM
Read more.